FDA

Elaine Thompson / AP Photo

An innovative new treatment for an aggressive form of blood cancer has been approved by the U.S. Food and Drug Administration.

The strain of lymphoma, targeted by the cell-based therapy, has a patient survival rate of about 40 percent, according to UPMC physician Mounzer Agha, director of the Mario Lemiuex Center for Blood Cancers at Hillman Cancer Center. He was involved in the new drug's clinical trails.

Former Exec Gets Probation, $5K Fine Over Imitation Cheese

Oct 11, 2016
Maggie Hoffman / Flickr

A former executive will spend three years on probation and pay a $5,000 fine because two Pennsylvania cheese businesses her family controlled sold grated Swiss and mozzarella cheeses that were mislabeled and represented as parmesan and romano.

A federal judge in Pittsburgh sentenced 44-year-old Michelle Myrter on Tuesday.

Although U.S. Food and Drug Administration inspection reports and consumer lawsuits have raised questions about whether the cheeses also had too much cellulose — a filler made from wood pulp — that wasn't an issue in the criminal case.

Hundreds of clinics around the country are offering to treat a long list of health problems with stem cells.

The clinics claim that stem cells found in fat tissue, blood, bone marrow and even placentas can help people suffering from arthritic joints and torn tendons to more serious medical problems, including spinal cord injuries, Parkinson's disease and strokes. Some even claim the cells can help children with autism.

But leading stem cell researchers say there's not enough evidence to support the clinics' claims.

Megan Harris / 90.5 WESA

The needle is in and out in a second. I let my breath return to its normal pace, and I’m given a Tweety Bird bandage as a reward for my maturity.